Mr. Hassan is director of private equity company Warburg Pincus, and he was previously chair and CEO of Schering-Plough. He also has experience at Pharmacia Corp., Amgen and Precigen. He received his MBA from Harvard Business School in Boston.
Prometheus Biosciences is a biotechnology company focused on diagnostics and treatment of inflammatory bowel disease and other immune-mediated diseases.
